Publications by authors named "Eric H Young"

While efforts have been made in the United States (US) to optimize antimicrobial use, few studies have explored antibiotic prescribing disparities that may drive future interventions. The objective of this study was to evaluate disparities in antibiotic prescribing among US ambulatory care visits by patient subgroups. This was a retrospective, cross-sectional study utilizing the National Ambulatory Medical Care Survey from 2009 to 2016.

View Article and Find Full Text PDF

Factor Xa (FXa) inhibitor use has increased over the last decade and though associated rates of major bleeding are lower compared to warfarin, outcomes from intracranial hemorrhage (ICH) are still significant. Targeted FXa inhibitor reversal agent became available in 2018, however use of 4-factor prothrombin complex concentrate (4F-PCC) for FXa inhibitor-associated ICH continues at many institutions. Evaluate the safety and hemostatic efficacy of 4F-PCC for FXa inhibitor-associated ICH.

View Article and Find Full Text PDF
Article Synopsis
  • * A total of 45,331 CDI cases were analyzed, revealing that older adults, males, Black, and Hispanic patients had the highest treatment costs and risks for severe CDI.
  • * Male sex and Black race were identified as significant factors associated with longer hospital stays and increased mortality rates, highlighting disparities in CDI management and outcomes.
View Article and Find Full Text PDF
Article Synopsis
  • - The study examined the prevalence of Clostridioides difficile infection (CDI) in US hospitals before and during the COVID-19 pandemic, finding that CDI encounters decreased from 12.2 to 8.9 per 10,000 total encounters.
  • - The decrease in CDI was mainly due to reduced inpatient CDI prevalence, but the rate at which CDI occurred did not significantly change over time.
  • - Despite the lower prevalence, patients with CDI during the pandemic experienced higher inpatient mortality rates and increased hospital costs compared to the pre-pandemic period.
View Article and Find Full Text PDF

Background/objectives: With an aging population suffering from increased prevalence of chronic conditions in the United States (U.S.), a large portion of these patients are on multiple medications.

View Article and Find Full Text PDF

Background: Influenza health resource utilization studies are important to inform future public health policies and prevent outbreaks. This study aimed to describe influenza prevalence, vaccination, and treatment among outpatients in the United States and to evaluate population-level characteristics associated with influenza health resource utilization.

Methods: Data were extracted from the National Ambulatory and National Hospital Ambulatory Medical Care Surveys (2009 to 2016).

View Article and Find Full Text PDF

Background: infection (CDI) is primarily mediated by alterations in the host gut ecosystem. While antibiotic use is the primary risk factor for CDI, other medications that modulate the gut ecosystem, particularly those targeting the gut-brain axis, could impact CDI risk. This study aimed to investigate the association between recent antidepressant and gamma-aminobutyric acid (GABA)-ergic medication use with CDI risk in a national cohort of United States veterans.

View Article and Find Full Text PDF

Background: Prior studies have found that outpatient antibiotics are commonly prescribed for non-bacterial conditions. It is unclear if national prescribing has changed in recent years given recent public health and antimicrobial stewardship initiatives. This study aimed to describe antibiotic prescribing in United States (U.

View Article and Find Full Text PDF

Growing evidence indicates that oral health and brain health are interconnected. Declining cognition and dementia coincide with lack of self-preservation, including oral hygiene. The oral microbiota plays an important role in maintaining oral health.

View Article and Find Full Text PDF

Clostridioides difficile infection (CDI) is the most common cause of nosocomial diarrhea and places a significant burden on patients and the health care system. Statins could lead to improvements in CDI clinical response due their pleiotropic effects, including immunomodulatory and lipid-lowering effects; however, few studies have assessed this association. The primary objective of this study was to compare CDI health outcomes in statin users and non-users in a national cohort of patients.

View Article and Find Full Text PDF